Literature DB >> 22125659

Treatment of widespread granuloma annulare with adalimumab: a case report.

Heidi Kozic, Guy F Webster.   

Abstract

The authors report a case of widespread granuloma annulare that was resistant to multiple systemic therapies, but responded rapidly to a short course of adalimumab.

Entities:  

Year:  2011        PMID： 22125659      PMCID： PMC3225136     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


  9 in total

1.  Generalized interstitial granuloma annulare--response to adalimumab.

Authors:  Siegfried Werchau; Alexander Enk; Martin Hartmann
Journal:  Int J Dermatol       Date:  2010-04       Impact factor: 2.736

2.  Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor.

Authors:  Zehra Kaymakcalan; Paul Sakorafas; Sahana Bose; Susanne Scesney; Limin Xiong; Denise Karaoglu Hanzatian; Jochen Salfeld; Eric H Sasso
Journal:  Clin Immunol       Date:  2009-02-01       Impact factor: 3.969

3.  Treatment of necrobiosis lipoidica with etanercept and adalimumab.

Authors:  Kevin S Zhang; Long T Quan; Sylvia Hsu
Journal:  Dermatol Online J       Date:  2009-12-15

Review 4.  Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases.

Authors:  F Dhaille; V Viseux; A Caudron; A Dadban; C Tribout; P Boumier; A Clabaut; C Lok
Journal:  Dermatology       Date:  2010-02-20       Impact factor: 5.366

5.  Treatment of therapy-resistant sarcoidosis with adalimumab.

Authors:  José Luis Callejas-Rubio; Norberto Ortego-Centeno; Lourdes Lopez-Perez; Maria Nicolas Benticuaga
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

6.  Successful treatment of disseminated granuloma annulare with adalimumab.

Authors:  David Rosmarin; Anne LaRaia; Scott Schlauder; Alice B Gottlieb
Journal:  J Drugs Dermatol       Date:  2009-02       Impact factor: 2.114

7.  Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors.

Authors:  S A Exarchou; P V Voulgari; T E Markatseli; A Zioga; A A Drosos
Journal:  Scand J Rheumatol       Date:  2009       Impact factor: 3.641

8.  Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.

Authors:  April Deng; Valerie Harvey; Bahram Sina; David Strobel; Ashraf Badros; Jacqueline M Junkins-Hopkins; Allen Samuels; Mana Oghilikhan; Anthony Gaspari
Journal:  Arch Dermatol       Date:  2006-02

9.  Granuloma annulare induced by anti-tumour necrosis factor therapy.

Authors:  P V Voulgari; T E Markatseli; S A Exarchou; A Zioga; A A Drosos
Journal:  Ann Rheum Dis       Date:  2007-08-29       Impact factor: 19.103
  9 in total
  1 in total

1.  ARE ANTIBIOTICS OF ANY USE IN THE MANAGEMENT OF GRANULOMA ANNULARE IN CHILDREN?

Authors:  Germaine Chia; Leila Ahmed; Peter Oligbu; Louis Odeigah; Godwin Oligbu
Journal:  Afr J Infect Dis       Date:  2019-07-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.